Acceptability of a decision-support electronic health record system and its impact on diabetes care goals in South Asia: a mixed-methods evaluation of the CARRS trial

Diabetic Medicine : a Journal of the British Diabetic Association
K SinghNikhil Tandon

Abstract

To describe physicians' acceptance of decision-support electronic health record system and its impact on diabetes care goals among people with Type 2 diabetes. We analysed data from participants in the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) trial, who received the study intervention (care coordinators and use of a decision-support electronic health record system; n=575) using generalized estimating equations to estimate the association between acceptance/rejection of decision-support system prompts and outcomes (mean changes in HbA1c , blood pressure and LDL cholesterol) considering repeated measures across all time points available. We conducted in-depth interviews with physicians to understand the benefits, challenges and value of the decision-support electronic health record system and analysed physicians' interviews using Rogers' diffusion of innovation theory. At end-of-trial, participants with diabetes for whom glycaemic, systolic blood pressure, diastolic blood pressure and LDL cholesterol decision-support electronic health record prompts were accepted vs rejected, experienced no reduction in HbA1c [mean difference: -0.05 mmol/mol (95% CI -0.22, 0.13); P=0.599], but statistically significant impr...Continue Reading

References

Oct 17, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Jul 27, 2006·JAMA : the Journal of the American Medical Association·Kaveh G ShojaniaDouglas K Owens
Aug 22, 2006·International Journal of Medical Informatics·Carolyn J GreenSylvia Robinson
Feb 27, 2007·Diabetes Care·Davis BuBlackford Middleton
Oct 28, 2010·Diabetes Care·Nadia A KhanHude Quan
Jul 5, 2012·BMC Medical Informatics and Decision Making·Qing WanSusanna Petche
Mar 26, 2013·Diabetes Research and Clinical Practice·Leonor Guariguata
Aug 21, 2013·Indian Journal of Endocrinology and Metabolism·Subhash K WangnooMala Dharmalingam
Dec 23, 2014·Diabetes Research and Clinical Practice·Roopa ShivashankarMahammed K Ali
Oct 4, 2015·Diabetes Research and Clinical Practice·Mohan DeepaUNKNOWN CARRS Surveillance Research Group
Jun 12, 2017·The Lancet. Diabetes & Endocrinology·Ranjit Mohan AnjanaUNKNOWN ICMR–INDIAB Collaborative Study Group

❮ Previous
Next ❯

Citations

Nov 21, 2019·Reviews on Recent Clinical Trials·Konstantinos VezertzisDimitrios Koutsouris
Aug 22, 2020·Yearbook of Medical Informatics·Ivana Jankovic, Jonathan H Chen
Nov 9, 2020·Canadian Journal of Diabetes·Paulina K WrzalNoah M Ivers

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
I OdnoletkovaD Ramaekers
Diabetic Medicine : a Journal of the British Diabetic Association
Ludwig MerkerEMPA-REG EXTEND MET investigators
Diabetic Medicine : a Journal of the British Diabetic Association
M TabeshD J Magliano
© 2022 Meta ULC. All rights reserved